Gold Daily And Silver Weekly Charts – Central Banks As Financial Cosmeticians
Friday was just one of those days where the ‘invisible hand’ tried to instill some confidence in the wise and benevolent judgement of the money masters, after a central bank, in this case the ECB, does something very visible and ‘lays an egg’ in doing it. So after all this yesterday, are you feeling more […]
Scotts Miracle-Gro – Chart Of The Day
The Chart of the Day belongs to Scotts Miracle-Gro (NYSE: SMG). I found the agricultural chemical stock by using Barchart to sort today’s All Time High list first for the highest number of new highs in the last month, then again for technical buy signals above 80%. Then I used the Flipchart feature to review the stocks. Since the Trend spotter signaled […]
Do These Funds Work? 3 ETFs Facing Uphill Challenges
ETF investors are always searching for unique strategies that offer promises of inflation protection or anti-volatility positioning. These funds are often drawn up using sophisticated back-testing analysis and touted as a strong “alternative” to compliment your existing portfolio of stocks and bonds. However, there are some instances where the strategy either falls flat from the […]
A Defensive Game Plan For This Friendless Market
I’m sure you’ve heard the popular saying… “The trend is your friend.” And also variations of it, like… “The trend is your friend… until it ends.” And my personal favorite… “The trend is your friend… until it stabs you in the back!” The idea here is simple: following along with your friend, the trend, is usually beneficial. […]
Two Charts To Consider Before The Monday Open
Deja-vu all over again… And what happened next? Trade accordingly…
E Sarepta’s Muscle Drug Gets New FDA Review Date
On Thursday shares of Sarepta Therapeutics (SRPT) closed up 15% for the day as the company stated that the FDA had set a new FDA independent panel review date. The original review date for Sarepta’s drug Eteplirsen was set to happen on January 20th. The problem was that a forecast of weather, that week forced […]
Why Bank Of America (BAC) Is My Favorite Bank Stock
Bank of America (BAC) is my favorite bank stock right now, and its future looks a lot brighter. The share price could double from here. Bank of America has underperformed for a number of years in an already-shaky banking sector, with added uncertainty regarding interest rates, economic growth, lending, income generation, and regulation. But the […]
Virtuix Sets Equity Crowdfunding Launch Date For March 23, 2016
Dear Early Investor, Big news in the equity crowdfunding world this week. Virtual reality startup Virtuix has announced that it will be open to the public for investment on March 23. The company plans to raise between $10 million and $15 million. This will be Virtuix’s Series A financing. It has raised $8 million to date. The share […]
S&P 500 Snapshot: A Four-Week Rally In Play
Yesterday’s market indecision (up and down head fakes ending in a flat finish) gave way to an unambiguous conviction. Our benchmark S&P 500 rallied at the open and rose in a couple of waves to its 1.64% closing gain, just a tick below its intraday high. The popular financial press offered a couple of explanations: […]
China Bank Activity And Total Social Financing Did Not Suggest Anything Good
China’s Total Social Financing hugely disappointed in February, as January’s surge was not followed as if renewed economic enthusiasm. The net flow was RMB 780 billion compared to the record RMB 3.42 trillion the month before. This latest update was instead among the lowest monthly totals since 2010. New loans added up to just RMB […]
